GSK Investigational Site

Xinxiang 453000

1 studies enrolling now · 2 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation — Recruiting now
• Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level — Completed